Solvay Loses False Advertising, Trademark Case

Law360, New York (March 6, 2007, 12:00 AM EST) -- KV Pharmaceutical Co. has won a seven-week trial in which Solvay Pharmaceuticals Inc. accused KV and a subsidiary of false advertising.

A federal jury in Minneapolis ruled in favor of KV and its generics subsidiary Ethex on Monday. A spokesman for the plaintiff said Tuesday that Solvay was still evaluating its options.

According to Solvay, Ethex falsely promoted its generic Pangestyme pancreatic enzyme products as bioequivalent versions of Solvay’s branded Creon microspheres.

Solvay accused the defendants of false advertising and unfair and deceptive trade practices....
To view the full article, register now.